Vivo Infusion Acquires Specialty Infusion Centers

Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services announced today it has acquired Specialty Infusion, an industry leader in ambulatory infusion and specialty pharmacy services, dedicated to convenient and affordable solutions for infusion patients in 14 ambulatory infusion centers in New York, Massachusetts, and New Jersey. With this acquisition, Vivo Infusion will advance to a combined 55 ambulatory infusion centers across ten states. Financial terms of the transaction were not disclosed.

Founded in 2018 by Elan Katz, a pharmacist by background, and Dr. Jake Deutsch, board certified in emergency medicine, Specialty Infusion provides affordable and accessible solutions to the high costs and often inconveniences of infusion care. Combining pharmacy expertise, clinical training and a deep understanding of patient care and experience, Elan and Dr. Deutsch have built a truly unique ambulatory infusion offering for a market previously underserved. Specialty Infusion offers a wide array of therapies across therapeutic areas including allergy/immunology, gastroenterology, neurology, and rheumatology and partners with health systems in its core markets to deliver high-quality, convenient, and affordable medical care to its patients.

"We are thrilled to welcome the Specialty Infusion team to the Vivo family," said Chris Reef, Chief Executive Officer of Vivo Infusion. "Specialty Infusion has built a market-leading ambulatory infusion business by identifying an unmet market need and choosing to prioritize the needs of their patients by delivering a unique model for infusion care that they knew to be superior. This is the promise of the ambulatory infusion center experience, and we are delighted to be partners with Elan, Jake and the entire Specialty Infusion team who recognize the same promise that we do here at Vivo."

"We founded Specialty Infusion because we saw an unmet need in our markets and knew we could do better for our patients than hospital-based, urgent care and other legacy infusion care settings," said Elan Katz. "We take great pride in what we have built thus far and know that we can do much more in partnership with the team at Vivo Infusion."

"Joining together with Vivo Infusion is not the end for our team, but rather an accelerant of our strategy," said Dr. Deutsch. "More than any other company that we met in the ambulatory infusion sector, the Vivo team understands we are here to deliver. Our combined entity places great emphasis on culture – excellent patient care, unrivaled patient experience, and care delivery that is aligned with system-wide goals. We have a bright future ahead of us all."

About Vivo Infusion

Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions. Vivo Infusion provides compassionate, expert care administered in safe, accessible facilities using efficient and cost-effective, patient-focused best practices. Vivo currently serves communities in Colorado, Connecticut, Florida, Massachusetts, Ohio, Oklahoma, Pennsylvania, New Jersey, New York, and Texas, with plans to expand into additional states. For more information, visit: vivoinfusion.com.

About Specialty Infusion

Specialty Infusion is a leading provider of ambulatory infusion and specialty pharmacy services, designed to safe, convenient, and affordable care for infusion patients to patients in New York, Massachusetts, and New Jersey. The Specialty Infusion leadership team and dedicated clinical staff are committed to excellence in clinical quality, affordability, and patient experience. For more information, please visit: specialtyinfusion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230620852747/en/